$Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin$

Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin

Aims: Low molecular weight heparins (LMWH) permit safe and effective treatment of uncomplicated deep venous thrombosis (DVT) at home. The aim of this study was to evaluate the cost minimization, cost shifting and patient satisfaction associated with at‐home DVT treatment using the LMWH enoxaparin, c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal medicine journal 2002-01, Vol.32 (1-2), p.29-34
Hauptverfasser:	Smith, B. J., Weekley, J. S., Pilotto, L., Howe, T., Beven, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - economics Anticoagulants - therapeutic use Cost Allocation Cost Control cost minimization deep venous thrombosis Drug Costs Enoxaparin - economics Enoxaparin - therapeutic use Female Heparin - economics Heparin - therapeutic use Home Care Services, Hospital-Based - economics Hospital Costs Humans low molecular weight heparin Male Medicare - economics Middle Aged Patient Satisfaction South Australia Venous Thrombosis - drug therapy Venous Thrombosis - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!